(MedPage Today) — Tirzepatide (Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, the FDA warned in an updated label.
GLP-1 medications for weight loss accounted for more than 7% of all…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119607
Author :
Publish date : 2026-01-27 18:22:00
Copyright for syndicated content belongs to the linked Source.
